Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 6 | 2024 | 1068 | 0.960 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 573 | 0.870 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 249 | 0.600 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 22 | 0.590 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 428 | 0.580 |
Why?
|
| Glucocorticoids | 1 | 2018 | 92 | 0.570 |
Why?
|
| Stress, Physiological | 1 | 2018 | 170 | 0.530 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 145 | 0.520 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 290 | 0.490 |
Why?
|
| Decision Making | 1 | 2018 | 242 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2020 | 467 | 0.470 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 860 | 0.420 |
Why?
|
| Mass Screening | 1 | 2018 | 531 | 0.420 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 2598 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 206 | 0.230 |
Why?
|
| Male | 7 | 2024 | 22779 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2018 | 722 | 0.190 |
Why?
|
| Humans | 9 | 2024 | 42163 | 0.170 |
Why?
|
| Research Personnel | 1 | 2020 | 191 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 187 | 0.150 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 34 | 0.150 |
Why?
|
| Protein Binding | 2 | 2018 | 1076 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 144 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2018 | 141 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 146 | 0.130 |
Why?
|
| Binding Sites | 1 | 2018 | 670 | 0.130 |
Why?
|
| Base Sequence | 1 | 2018 | 997 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 534 | 0.120 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 8 | 0.120 |
Why?
|
| Antibodies, Antinuclear | 1 | 2015 | 17 | 0.120 |
Why?
|
| Antibody Specificity | 1 | 2015 | 76 | 0.120 |
Why?
|
| Gene Expression | 1 | 2018 | 692 | 0.120 |
Why?
|
| United States | 2 | 2024 | 5072 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2803 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 959 | 0.090 |
Why?
|
| Middle Aged | 3 | 2024 | 11819 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3077 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2018 | 2111 | 0.080 |
Why?
|
| Aged | 2 | 2019 | 7982 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1679 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 4936 | 0.070 |
Why?
|
| Adult | 1 | 2018 | 13458 | 0.050 |
Why?
|
| Incidence | 1 | 2024 | 1054 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 1221 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2019 | 90 | 0.040 |
Why?
|
| Hela Cells | 1 | 2019 | 370 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2024 | 705 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 3942 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 181 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 223 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 246 | 0.030 |
Why?
|
| Female | 1 | 2019 | 24018 | 0.010 |
Why?
|